Related Experiment Video
Updated: Apr 29, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of
Xin Yi1, Xiaoyan Li1, Yanli Zhou1
1Department of Cardiology, Renmin Hospital of Wuhan University and Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Insights
Hepatocyte growth factor (HGF) inhibits cardiac fibroblast proliferation and transformation, key drivers of cardiac fibrosis. HGF activates the c-Met-Akt-TGIF pathway, offering a potential therapeutic target for heart conditions.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Fibrosis Research
Background:
- Cardiac fibroblast (CF) proliferation and myofibroblast transformation are central to cardiac fibrosis and pathological myocardial remodeling.
- Transforming growth factor-β1 (TGF-β1) is a known inducer of these fibrotic processes.
Purpose of the Study:
- To investigate the role of hepatocyte growth factor (HGF) as a regulator of cardiac fibroblast behavior in response to TGF-β1.
- To elucidate the underlying molecular mechanisms by which HGF influences cardiac fibroblast activation.
Main Methods:
- Assessing HGF expression levels in CFs treated with TGF-β1.
- Modulating HGF levels (overexpression and knockdown) in CFs.
- Evaluating CF proliferation, transformation (α-smooth muscle actin, collagen I/III expression), and secretory function.
- Analyzing the phosphorylation of c-Met, Akt, and TGIF protein.
Main Results:
- HGF expression decreased in CFs upon TGF-β1 treatment.
- HGF overexpression suppressed TGF-β1-induced CF proliferation, transformation, and secretion, reducing α-SMA and collagen I/III levels.
- HGF knockdown exacerbated TGF-β1-induced CF activation.
- HGF modulated the phosphorylation of c-Met, Akt, and TGIF.
Conclusions:
- HGF acts as a negative regulator of cardiac fibroblast activation and transformation.
- HGF exerts its antifibrotic effects by activating the c-Met-Akt-TGIF signaling pathway.
- Targeting the HGF-c-Met-Akt-TGIF axis may represent a novel therapeutic strategy for mitigating cardiac fibrosis.
Abstract:
Cardiac fibroblast (CF) proliferation and transformation into myofibroblasts play important roles in cardiac fibrosis during pathological myocardial remodeling. In this study, we demonstrate that hepatocyte growth factor (HGF), an antifibrotic factor in the process of pulmonary, renal and liver fibrosis, is a negative regulator of cardiac fibroblast transformation in response to transforming growth factor‑β1 (TGF‑β1). HGF expression levels were significantly reduced in the CFs following treatment with 5 ng/ml TGF‑β1 for 48 h. The overexpression of HGF suppressed the proliferation, transformation and the secretory function of the CFs following treatment with TGF‑β1, as indicated by the attenuated expression levels of α-smooth muscle actin (α‑SMA) and collagen I and III, whereas the knockdown of HGF had the opposite effect. Mechanistically, we identified that the phosphorylation of c‑Met, Akt and total protein of TGIF was significantly inhibited by the knockdown of HGF, but was significantly enhanced by HGF overexpression. Collectively, these results indicate that HGF activates the c‑Met‑Akt‑TGIF signaling pathway, inhibiting CF proliferation and transformation in response to TGF‑β1 stimulation.
Related Concept Videos
TGF - β Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Introduction to Fibroblasts
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Healing I: Introduction
Regulation of Angiogenesis and Blood Supply

